TABLE 2.
Chr | Position | Gene | Sequence (5′-3′) | Blastomeres with de novo variants | |
---|---|---|---|---|---|
gRNA 1 | 2 | 101,400,689–101,400,711 | CCR5* | GCTGCTGCCCAGTGGGACTT | |
1 | 63,497,146–63,497,168 | NFASC | C GCTGCCCAGTG GACTT | 4-4, 4-5, 5-3, 5-4, 5-7, 5-8, 5-9 | |
1-scaffold | 378,063–378,085 | intergenic_ke145507.1 | GCTGCTGCCCAGT G CTT | 4-4, 4-6 | |
10 | 31,267,650–31,267,672 | intergenic_CM001928.1 | CTGCTGCCCAGTGGG CT | 5-1 | |
19 | 40,019,282–40,019,304 | DLL3 | GC CTGC CAGTGGGACTT | 4-4, 4-6, 5-3 | |
gRNA 2 | 2 | 101,400,887–101,400,909 | CCR5* | GCTGTGTTTGCCTCTCTCCC | |
7 | 35,664,631–35,664,653 | LIPC | GCTGTG TTGCCTCT TCCC | 4-5, 4-6, 5-1 | |
9 | 7,497,178–7,497,200 | SFMBT2 | GCTG TTTGCCTCTCTCCC | 4-3, 4-6, 5-5, 5-7, 5-8 | |
11 | 129,547,583–129,547,605 | intergenic_CM001929.1 | GCTGTG TT CCTCTCTCCC | 4-5, 4-6, 5-1, 5-5 | |
14 | 14,725,950–14,725,972 | intergenic_CM001932.1 | GCTGTGTT CCTCTCTCCC | 4-5, 4-6, 5-4 | |
1 | 199,634,457–199,634,479 | intergenic_CM001919.1 | GCTGTG TT CCTCTCTCC | 5-3 | |
3 | 53,360,905–53,360,927 | intergenic_CM001921.1 | CTGTG TT CCTCTCTCCC | 4-3, 4-5, 5-1, 5-5 | |
4 | 2,457,033–2,457,055 | intergenic_CM001922.1 | GCTGTGT T CCTCTC CCC | 5-1 | |
5 | 188,649,889–188,649,911 | intergenic_CM001923.1 | TGTGTTTGCCTCT TCCC | 4-3, 5-1, 5-4, 5-7, 5-8, 5-9 | |
7 | 28,263,588–28,263,610 | CYP19A1 | G GTGTT GCCTCTCTCCC | 5-7 | |
12 | 62,901,723–62,901,745 | intergenic_CM001930.1 | GCTGTGT GCCTCTCTC C | 4-1, 4-3, 5-3, 5-5, 5-8 | |
17 | 62,039,482–62,039,504 | NDFIP2 | GCTGT TTTGCC CTCTC C | 4-3 | |
19 | 49,110,480–49,110,502 | CCDC114 | GCTGTG T CCTCTCTCCC | 5-1, 5-3, 5-4, 5-8 |
A total of 93 regions were assessed that contained 2-3 mismatches. *Denotes on-target gene sequence. Chr: chromosome.